Summary
This paper explores the evidence base for services designed to meet the needs of people who experience homelessness and use drugs (PEHAD). Through a delimited analysis of existing systematic and rapid evidence reviews, it considers the key lessons for the development of effective homelessness services in Europe. The aims of the paper are two-fold. Its first objective is to identify the gaps and limitations in our understanding of what constitutes homelessness, as well as the holes in the existing evidence base around service provision for those experiencing homelessness. The second goal is to draw on the available research to explore what is available in terms of practical knowledge transfer, i.e. evidence that might enhance homelessness prevention and services.
Download as PDF
European responses to the needs of people who experience homelessness and use drugs
PDF files are made available as a convenience. In cases where the EMCDDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoritative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.
Additional information
This paper was commissioned by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) to provide background information to inform and contribute to the drafting of Health and social responses to drug problems: a European guide.
This background paper was produced under contract CT.19.HEA.0092.1.0 and we are grateful for the valuable contribution of the author. The paper has been cited within Health and social responses to drug problems and is also being made available online for those who would like further information on the topic. However, the views, interpretations and conclusions set out in this publication are those of the author and are not necessarily those of the EMCDDA or its partners, any EU Member State or any agency or institution of the European Union.